SOLV8 Technology
SOLV8 Technology's vision is to achieve sustainable and energy-efficient solvent recovery for the industries. We have invented a novel membrane technology to recover high-purity solvents with high separation efficiency, enabling the solvents to be reused in the process. With our patent application filed in Singapore, we strive to minimize the carbon footprint of separation processes by cutting the energy consumption by 90%.
Industry
Nearly a billion tons of solvents need to be recovered every year. Solvent recovery is currently achieved by boiling off the solvent. Such processes are energy-intensive and account for 40% of energy costs in process plants. Globally, 460 million tons of solvents need to be recovered and reused every year across various industries.
Recover solvents from edible oil
Remove acid, odor & color from palm oil
Concentrate active pharmaceutical ingredients from the reaction mixture, dehydrate glycerine
Oleochemical, flavour and fragrance markets also require solvent recovery in its manufacturing processes
Problem & Solution
Problem
Thermal separation processes are energy-intensive. And the high operating temperature can result in product degradation, solvent loss, and poses serious health, safety and environmental hazards.
Solution
SOLV8 membrane system offers the most cost-effective way for effective solvent recovery. Compared with competitors, our membrane is far more cost effective, and offers 10X higher impurity rejection and 10X higher throughput.
About Us
A Novel Membrane Technology
SOLV8 is a NUS spin-off company with a vision to achieve sustainable and energy efficient solvent recovery for the industries. We have invented a novel membrane technology to recover high-purity solvents with high separation efficiency, enabling the solvents to be reused in the process. With our patent application filed in Singapore, we strive to minimize the carbon footprint of separation processes by cutting the energy consumption by ~90%.
Our Product
● Energy Efficient
● Low Solvent Loss
● Flexible Capacity
● Plug & Play
● Safe
Material
-
Commercially available
-
FDA approved
-
No cross-linking
Configuration
-
Spiral wound
-
Automated production
-
Minimized swelling
Performance
-
5x throughput
-
10x rejection
-
10x energy efficient
Our Team
Wan Chunfeng
CEO
Shi Guimin
CTO
Professor Neal Chung
Scientific Advisor
Shekhar Kinjavdekar
Business Advisor
Supported By
